Trade MIST anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Milestone Pharmaceuticals Inc. Common Shares (MIST) is trading at US$1.20, down 0.83% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$131.35M. Over the past 52 weeks, MIST has traded between US$1.00 and US$3.06. On Syfe you can trade MIST with $0 commission and add it to your watchlist.
| Previous close | US$1.21 |
|---|---|
| Market cap | US$131.35M |
| 52-week range | US$1.00 – US$3.06 |
| Volume | 1.58M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Milestone Pharmaceuticals Inc. Common Shares
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.
Year: 2019
Milestone Pharmaceuticals Files $300 Million Mixed Shelf
May 13, 9:52 PM · MT Newswires
Raymond James Initiates Milestone Pharmaceuticals at Strong Buy
Apr 10, 11:30 AM · MT Newswires
Stay on top of MIST
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
